Profile: PaxVax develops candidate oral vaccines for influenza, and other key infectious diseases. We offer an oral vaccine technology based on a common virus called adenovirus that removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel. Our vaccines can also be produced in record speed, in large quantities, and at low expense compared to traditional egg-based vaccines such as those against seasonal or pandemic flu.